- জেনেরিক নাম
- Pyrazinamide
- শক্তি
- 500 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- G. A. Company Ltd.
Pyramide Tablet
Pyramide 500 mg Tablet সম্পর্কে
Pyramide 500 mg Tablet একটি ট্যাবলেট ঔষধ, যার জেনেরিক নাম Pyrazinamide এবং শক্তি ৫০০ mg। Pyramide-এর সাথে Pyrazinamide-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। এই ব্র্যান্ডের প্রস্তুতকারক G. A. Company Ltd। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।
Pyrazinamide-এর ৪টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত।
Pyramide 500 mg Tablet কী?
Pyramide 500 mg Tablet is a prescription anti-tubercular medicine from G. A. Company Ltd. Its active ingredient is pyrazinamide, which belongs to the anti-tubercular chemotherapeutics group. It is not used on its own: treatment of active tuberculosis combines it with other anti-tubercular agents, and the full course is planned by a doctor. Pyrazinamide works against the bacteria that cause tuberculosis, and its effect can depend on the drug level reached at the site of infection and on how susceptible the bacteria are. Because tuberculosis treatment is specialised, the doctor decides the combination, the dose and how long it is taken, and arranges the tests and monitoring needed during therapy.
Pyramide-এর ব্যবহার
Pyramide 500 mg Tablet is used for the initial treatment of active tuberculosis in adults and children. It is given together with other anti-tubercular medicines rather than alone. Guidelines for drug-susceptible disease describe multi-drug regimens that include pyrazinamide in the first part of treatment, but the exact plan depends on the person's case. The doctor decides which medicines are combined and for how long.
Pyramide কীভাবে ব্যবহার করবেন
Pyramide 500 mg Tablet is taken by mouth. The doctor sets the dose, how often it is taken and the length of the course, based on the person's weight, age and condition, and it is taken as part of a combination regimen. Follow the doctor's instructions exactly and do not stop or change the medicine on your own. Ask the doctor or pharmacist if you are unsure how to take it or what to do if you miss a dose.
Pyramide-এর পার্শ্বপ্রতিক্রিয়া
The main adverse effect reported with pyrazinamide is a liver reaction, which may be dose related and can appear at any time during treatment. Stomach upset such as nausea, vomiting and loss of appetite has also been reported. Other reported effects include gout, fever, joint and muscle pain, and rarely blood-related changes. Tell your doctor promptly about symptoms such as yellowing of the skin or eyes, dark urine, severe stomach upset or joint pain.
সতর্কতা ও নিরাপত্তা
Pyramide 500 mg Tablet is not for people with severe liver damage, acute gout, or a known allergy to pyrazinamide. Liver function and uric acid levels are checked before and during treatment, and people with existing liver disease need close monitoring. The medicine is stopped if signs of liver damage or gouty arthritis appear. In pregnancy it is given only when clearly needed, and in nursing mothers the risks and benefits are weighed. Tell the doctor about pregnancy, breastfeeding, liver problems, gout or other medicines you take.
সাধারণ প্রশ্ন
What is Pyramide 500 mg Tablet used for and what kind of medicine is it?
It is an anti-tubercular medicine containing pyrazinamide. It is used in the initial treatment of active tuberculosis in adults and children, always together with other anti-tubercular medicines. It is not used alone, and the doctor plans the full combination and course.
How should Pyramide 500 mg Tablet be taken?
It is taken by mouth, but the doctor decides the dose, how often it is taken and how long the course lasts, based on your weight, age and condition. Take it exactly as prescribed and do not stop it on your own. Ask your doctor or pharmacist if anything is unclear.
Who should avoid Pyramide 500 mg Tablet or ask the doctor first?
It should not be used by people with severe liver damage, acute gout or a known allergy to pyrazinamide. People with liver disease, gout, pregnancy or breastfeeding should tell the doctor first. Always mention other medicines you take so the doctor can check for interactions.
What should I do if I notice side effects while taking it?
Contact your doctor promptly if you develop yellowing of the skin or eyes, dark urine, severe nausea or vomiting, loss of appetite, or joint pain. Liver reactions are the main concern with pyrazinamide, and the doctor will decide whether the medicine should be stopped or your treatment changed.
আরও পাওয়া যায়
নির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pyrazinamide is indicated for the initial treatment of active tuberculosis in adults and children when combined with other antituberculous agents.- The current recommendation of the CDC for drug-susceptible disease is to use a six-month regimen for initial treatment of active tuberculosis, consisting of isoniazid, rifampin and Pyrazinamide given for 2 months, followed by isoniazid and rifampin for 4 months ... Read more
- The current recommendation of the CDC for drug-susceptible disease is to use a six-month regimen for initial treatment of active tuberculosis, consisting of isoniazid, rifampin and Pyrazinamide given for 2 months, followed by isoniazid and rifampin for 4 months
- Patients with drug-resistant disease should be treated with regimens individualized to their situation. Pyrazinamide frequently will be an important component of such therapy.
- In patients with concomitant HIV infection, the physician should be aware of current recommendation of CDC. It is possible these patients may require a longer course of treatment
Pyrazinamide should only be used in conjunction with other effective antituberculous agents.
ফার্মাকোলজি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pyrazinamide may be bacteriostatic or bactericidal in action, depending on the concentration of the drug attained at the site of the infection and the susceptibility of the infecting organism. Its activity appears to partly depend on conversion of the drug to pyrazinoic acid (POA), which lowers the pH of the environment below that which is necessary for growth of Mycobacterium tuberculosis. Susceptible strains of M. tuberculosis produce pyrazinamidase, an enzyme that deaminates pyrazinamide to POA, and the in vitro susceptibility of a given strain of the organism appears to correspond to its pyrazinamidase activity.মাত্রা ও সেবনবিধি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Usual Adult Dose for Tuberculosis: Active:
15 to 30 mg/kg (up to 2 g) orally once a day in combination with three other antituberculous drugs for the initial 2 months of a 6-month or 9-month treatment regimen, until drug susceptibility tests are known. An alternate dosing regimen of 50 to 75 mg/kg (up to 3 g) orally twice a week may be used after 2 weeks of daily therapy to increase patient compliance.Alternatively, the CDC, The American Thoracic Society, and the Infectious Diseases Society of America suggest the following dosing based on estimated lean body weight:
Daily dosing:
- 40 to 45 kg: 1000 mg
- 56 to 75 kg: 1500 mg
- 76 to 90 kg: 2000 mg
- 40 to 55 kg: 2000 mg
- 56 to 75 kg: 3000 mg
- 76 to 90 kg: 4000 mg
- 40 to 55 kg: 1500 mg
- 56 to 75 kg: 2500 mg
- 76 to 90 kg: 3000 mg
Usual Adult Dose for Tuberculosis: Latent:
A public health expert should be consulted prior to the use of the combination regimen with rifampin.15 to 20 mg/kg, based on actual body weight (lean), orally once daily (maximum 2 g) for 2 months. Alternatively, a dosage of 50 mg/kg may be administered orally twice-weekly (maximum 4 g).
Usual Pediatric Dose for Tuberculosis: Active:
(Used as part of a multidrug regimen. Treatment regimens consist of an initial 2-month phase, followed by a continuation phase of 4 or 7 additional months. Frequency of dosing may differ depending on phase of therapy)Infants, Children less than 40 kg and Adolescents 14 years and younger and less than 40 kg:
Non-HIV patients:
- Daily therapy: 15 to 30 mg/kg/dose (maximum: 2 g/dose) once daily
- Directly observed therapy (DOT): 50 mg/kg/dose (maximum: 2 g/dose) twice weekly
- Daily therapy: 20 to 40 mg/kg/dose once daily (maximum: 2 g/day)
ঔষধের মিথষ্ক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Antagonises the effect of uricosuric agents (e.g. probenecid, sulfinpyrazone). May reduce the contraceptive effect of oestrogens. May inactivate oral typhoid vaccine. May increase the serum concentration of ciclosporin. May enhance the hepatotoxic effect of rifampicin.প্রতিনির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pyrazinamide is contraindicated in persons:- With severe hepatic damage.
- Who have shown hypersensitivity to it.
- With acute gout.
পার্শ্ব প্রতিক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
General: Fever, porphyria and dysuria have rarely been reported. Gout.Gastrointestinal: The principal adverse effect is a hepatic reaction. Hepatotoxicity appears to be dose related, and may appear at any time during therapy. GI disturbances including nausea, vomiting and anorexia have also been reported.
Hematologic and Lymphatic: Thrombocytopenia and sideroblastic anemia with erythroid hyperplasia, vacuolation of erythrocytes and increased serum iron concentration have occurred rarely with this drug. Adverse effects on blood clotting mechanisms have also been rarely reported.
Other: Mild arthralgia and myalgia have been reported frequently. Hypersensitivity reactions including rashes, urticaria, and pruritis have been reported. Fever, acne, photosensitivity, porphyria, dysuria and interstitial nephritis have been reported rarely.
গর্ভাবস্থায় ও স্তন্যদানকালে
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregnancy Category C. Animal reproduction studies have not been conducted with Pyrazinamide. It is also not known whether Pyrazinamide can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Pyrazinamide should be given to a pregnant woman only if clearly needed.Nursing Mothers: Pyrazinamide has been found in small amounts in breast milk. Therefore, it is advised that Pyrazinamide be used with caution in nursing mothers taking into account the risk-benefit of this therapy.
সতর্কতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pyrazinamide is contraindicated in patients with severe hepatic disease and with acute gout.Patients started on pyrazinamide should have baseline serum uric acid and liver function test results. Liver function should be monitored closely during therapy. Patients with preexisting liver disease or those at increased risk of drug related hepatitis should be monitored closely.
Pyrazinamide should be discontinued and not restarted if signs of hepatocellular damage or hyperuricemia with an acute gouty arthritis appear.
Polyarthralgias have been reported in patients. The pain may respond to aspirin or other nonsteroidal anti-inflammatory agents.
Caution should be used in patients with a history of diabetes mellitus, as management of the disease may be more difficult.
Primary resistance of Mycobacterium tuberculosis to pyrazinamide is not common. In cases with known or suspected drug resistance, in vitro susceptibility tests with recent cultures of Mycobacterium tuberculosis against pyrazinamide and the usual primary drugs should be conducted. There are few reliable in vitro tests for pyrazinamide resistance. A reference laboratory capable of performing these tests must be utilized.
Clinical experience has not identified differences in responses between elderly and younger patients. In general, dose selection for elderly patients should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased renal or hepatic function, and of concomitant disease or other drug therapy.
মাত্রাধিক্যতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Overdosage experience is limited. In one case report of overdose, abnormal liver function tests developed. These spontaneously reverted to normal when the drug was stopped. Clinical monitoring and supportive therapy should be employed. Pyrazinamide is dialyzable.সংরক্ষণ
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Store between 15-30° C.বিকল্প ব্র্যান্ড: Pyrazinamide
একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।